Well done Mid Cheshire Hospitals 🏥 research team top recruiter to the MAPS-2 this month. Offering #strokerearch to all of our patients @NIHRCRN_nwcoast #stroke #research

🔴 We've gone #Red4Research today to show our gratitude for all those who make research possible. Join us by posting a photo of yourself in red to show your support! 🔴

Huge thank you to our top recruiting sites in August 2024! The Royal Wolverhampton NHS Trust 🏥 Hull University Teaching Hospitals NHS Trust Craigavon Hospital Fife EM #strokeresearch #MAPS2 #clinicalresearch 👏👏👏

It’s #WorldStrokeDay. Most common sign of a #stroke is sudden weakness of the face, arm, or leg, often on one side of the body. Other symptoms include dizziness, loss of balance and sudden difficulty speaking, seeing or walking. If you or someone you know experiences these

On World Stroke Day, the team at University of Nottingham would like to thank everyone who has supported our trials! 💝THANK YOU #WorldStrokeDay #StrokeAwareness #WorldStrokeDay2024 MAPS-2 PhEAST Trial TICH-3 Trial RECAST-3 Trial MACE-ICH trial Uni of Nottingham Press Office

#UKSF2024 Stroke Trials Unit Nottingham - please join us at the Investigator meetings, Poster presentation and say 👋 to the team at stand A 1⃣6⃣. Please get in touch if there are any queries 💖 ENOS-2 MACE-ICH trial MAPS-2 PhEAST Trial RECAST-3 Trial TICH-3 Trial 🫠

Well done to #teamNASU South Tees Hospitals on recruiting 2 patients for MAPS-2 and our first RECAST-3 Trial patient within 24 hours !!! Looking forward to seeing the Stroke Trials Unit, Nottingham team next week @ #UKSF24 🤩🥳

WE ARE HERE! Please visit us at stand A16! 💝 Please join us for the Investigator meetings today 3.30 - 4.15pm at room 12 where there will be updates on PhEAST, ReCAST-3 and MAPS-2 🌈PhEAST Trial RECAST-3 Trial MAPS-2 TICH-3 Trial MACE-ICH trial ENOS-2 #uksf24 #UKSF24

Day 1 - Thank you to the many who attended to see Prof. Bath, Prof. Roffe & Prof. England who presented their respective trials PhEAST Trial MAPS-2 RECAST-3 Trial . See you tomorrow MACE-ICH trial TICH-3 Trial ENOS-2 #uksf24 #UKSF24 ❤️‍🔥

Please join us today at 10.40-11.25am at room 12 where Dr Krishnan MACE-ICH trial , Prof Sprigg TICH-3 Trial & Prof Bath #FASTEST will be presenting. Big thank you to those who attended Dr Woodhouse's ENOS-2 presentation earlier this morning 👏 #UKSF24 #uksf24

Really thankful for the turnout to see Dr Krishnan, Prof Sprigg & Prof Bath present MACE-ICH trial TICH-3 Trial & #FASTEST. Thank you to those who attended to see Dr Woodhouse present ENOS-2 Some more updates to follow for tomorrow! #uksf24 #UKSF24

[1/2] Thurs 5th : Please join us where Dr Menon will be presenting “Sex Matters in Intracerebral Haemorrhage”, 9.00am, room 3. Prof. Wardlaw & Kasia Adamczuk will be presenting LACI-3, 10.30am, room 12. #uksf24 #UKSF24

[2/2] Prof. Sprigg will be presenting “Should we be using Andexanet in the NHS ?” from 11.20am, room 3 #uksf24 #UKSF24

Day 3: 🌈Dr Chaamanti Menon who gave a wonderful presentation in "Sex Matters in ICH. Sex Disparity Analysis from TICH-2 Data" at Women's Health in Stroke 👏 #uksf24 #UKSF24

Andrew Young is one of our #NASU Nurse ACP South Tees Hospitals who is also PI MAPS-2. 👏🏾👏🏾👏🏾 on your e-poster displayed #UKSF24 . Thank you for being a role model for nurses as principal investigators. #takeupstroke

Professor Christine Roffe, winner of our #UKSF24 British & Irish Association of Stroke Physicians President’s Prize!👇

Thank you to all who have helped us this year! Merry Christmas and Happy New Year from MAPS-2!

Happy International Nurses Day to all the nurses at our MAPS-2 sites. Thank you for all you do to support our trial! #InternationalNursesDay2025 #strokeresearch

[1/4] ESOC 2025: Hi! If you are attending ESOC, please see the poster presentation for several of our trials from Stroke Trials Unit, Nottingham 🙏: Wednesday 21st May: -RECAST-3, (Poster session I - Acute Ischemic Stroke Management)

Hi! Dr Jen Craig & Becca Ward from Stroke Trials Unit, Nottingham will be attending Welsh Stroke Conference today and tomorrow - please say Hi! We really appreciate the support shown to our trials! ☀️MACE-ICH trial RECAST-3 Trial TICH-3 Trial MAPS-2 PhEAST Trial